Jamieson is pleased to announce that it has advised the management team of Centauri Health Solutions in connection with the closing of a $780m continuation vehicle for Abry Partners. Funds managed by Neuberger Private Markets (“Neuberger”) and Apollo’s Sponsor and Secondary Solutions business (“Apollo S3”) served as co-lead investors in the transaction.
Centauri Health Solutions, founded in 2014, delivers market-leading technology that solves complex, mission-critical challenges for U.S. health plans and health systems, provides data intelligence and member engagement solutions to U.S. health plans, and provides data-driven solutions that transform fragmented clinical data into actionable intelligence.
Michael Sirkin, Evan Alper, Matthew Schwarcz, and Rebecca Redmond advised Mike McNelis (CEO & Co-Founder), Adam Miller (Executive Chairman), and the management team on their reinvestment into the new structure and the terms of the new equity incentive plan.
Jamieson Corporate Finance US, LLC is a member of FINRA (www.finra.org) / SIPC (www.sipc.org). This notification appears as a matter of record only and is not an offer to sell or a solicitation of an offer to buy any securities.
